Sickle Cell Leg Ulcer Successfully Managed by Hyperbaric Oxygen: a Case Report

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2023 Jul 3

PMID 37396892

Authors

Awni Alshurafa

Mohammed Alkhatib

Mohammad Abu-Tineh

Mohamed A Yassin

Affiliations

Soon will be listed here.

Abstract

Sickle cell leg ulcers (SCLUs) are usually chronic, painful, and devastating complications of sickle cell disease. Skin vaso-occlusion with compromised blood flow, chronic inflammation, and endothelial dysfunction is thought to be the underlying mechanism. It is usually slow to heal, and it may become chronic and superinfected. The management of SCLUs is usually challenging and requires a multidisciplinary team. Multiple systemic and local therapies have been tried in SCLU treatment. However, the outcome is variable: currently, there are no official recommendations for the best effective treatment. Herein, we report a 34-year-old male patient with non-transfusion-dependent sickle cell disease who was suffering from a chronic left ankle ulcer and was successfully managed with hyperbaric oxygen therapy, resulting in a complete resolution of this devastating complication.

Citing Articles

The Curious Case of a Painful Leg Ulcer.

Patel J, Montejano R, Hopkins C, Siatecka H, Rosen T Cureus. 2024; 16(2):e54127.

PMID: 38487135 PMC: 10939161. DOI: 10.7759/cureus.54127.

References

Powars D, Chan L, Hiti A, Ramicone E, Johnson C . Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (Baltimore). 2005; 84(6):363-376. DOI: 10.1097/01.md.0000189089.45003.52. View

Monfort J, Senet P . Leg Ulcers in Sickle-Cell Disease: Treatment Update. Adv Wound Care (New Rochelle). 2020; 9(6):348-356. PMC: 7155924. DOI: 10.1089/wound.2018.0918. View

Kato G, Hebbel R, Steinberg M, Gladwin M . Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions. Am J Hematol. 2009; 84(9):618-25. PMC: 3209715. DOI: 10.1002/ajh.21475. View

Sen C . Wound healing essentials: let there be oxygen. Wound Repair Regen. 2009; 17(1):1-18. PMC: 2704021. DOI: 10.1111/j.1524-475X.2008.00436.x. View

Delaney K, Axelrod K, Buscetta A, Hassell K, Adams-Graves P, Seamon C . Leg ulcers in sickle cell disease: current patterns and practices. Hemoglobin. 2013; 37(4):325-32. PMC: 3864012. DOI: 10.3109/03630269.2013.789968. View

Ortega M, Fraile-Martinez O, Garcia-Montero C, Callejon-Pelaez E, Saez M, Alvarez-Mon M . A General Overview on the Hyperbaric Oxygen Therapy: Applications, Mechanisms and Translational Opportunities. Medicina (Kaunas). 2021; 57(9). PMC: 8465921. DOI: 10.3390/medicina57090864. View

Minniti C, Eckman J, Sebastiani P, Steinberg M, Ballas S . Leg ulcers in sickle cell disease. Am J Hematol. 2010; 85(10):831-3. PMC: 2953786. DOI: 10.1002/ajh.21838. View

Gill A, Bell C . Hyperbaric oxygen: its uses, mechanisms of action and outcomes. QJM. 2004; 97(7):385-95. DOI: 10.1093/qjmed/hch074. View

Alshurafa A, Yassin M . Short- and long-term follow-up and additional benefits in a sickle cell disease patient experienced severe crizanlizumab infusion-related vaso-occlusive crisis: A case report. Front Med (Lausanne). 2022; 9:1048571. PMC: 9745667. DOI: 10.3389/fmed.2022.1048571. View

10.

Umeh N, Ajegba B, Buscetta A, Abdallah K, Minniti C, Bonham V . The psychosocial impact of leg ulcers in patients with sickle cell disease: I don't want them to know my little secret. PLoS One. 2017; 12(10):e0186270. PMC: 5646800. DOI: 10.1371/journal.pone.0186270. View

11.

Minniti C, Knight-Madden J, Tonda M, Gray S, Lehrer-Graiwer J, Biemond B . The impact of voxelotor treatment on leg ulcers in patients with sickle cell disease. Am J Hematol. 2021; 96(4):E126-E128. PMC: 7986764. DOI: 10.1002/ajh.26101. View

12.

Wali Y, Kini V, Yassin M . Distribution of sickle cell disease and assessment of risk factors based on transcranial Doppler values in the Gulf region. Hematology. 2020; 25(1):55-62. DOI: 10.1080/16078454.2020.1714113. View

13.

Boykin Jr J, Baylis C . Hyperbaric oxygen therapy mediates increased nitric oxide production associated with wound healing: a preliminary study. Adv Skin Wound Care. 2007; 20(7):382-8. PMC: 2756815. DOI: 10.1097/01.ASW.0000280198.81130.d5. View

14.

Rozi W, Rahhal A, Ali E, Al-Mashdali A, Hilan Y, Khamees I . Direct oral anticoagulants in sickle cell disease: a systematic review and meta-analysis. Blood Adv. 2022; 6(17):5061-5066. PMC: 9631619. DOI: 10.1182/bloodadvances.2022007308. View

15.

Antwi-Boasiako C, Andemariam B, Colombatti R, Asare E, Strunk C, Piccone C . A study of the geographic distribution and associated risk factors of leg ulcers within an international cohort of sickle cell disease patients: the CASiRe group analysis. Ann Hematol. 2020; 99(9):2073-2079. PMC: 7430152. DOI: 10.1007/s00277-020-04057-8. View

16.

Tolu S, Crouch A, Choi J, Gao Q, Reyes-Gil M, Ogu U . Hydroxyurea and fetal hemoglobin effect on leg ulcers in patients with sickle cell disease. Ann Hematol. 2022; 101(3):541-548. DOI: 10.1007/s00277-021-04635-4. View

17.

Alshurafa A, Elhissi M, Yassin M . Complete resolution of stage II avascular necrosis affecting three joints by hyperbaric oxygen in a patient with sickle cell disease: A case report. Front Med (Lausanne). 2022; 9:1063255. PMC: 9748694. DOI: 10.3389/fmed.2022.1063255. View

18.

Ata F, Rahhal A, Malkawi L, Iqbal P, Khamees I, Alhiyari M . Genotypic and Phenotypic Composition of Sickle Cell Disease in the Arab Population - A Systematic Review. Pharmgenomics Pers Med. 2023; 16:133-144. PMC: 9961577. DOI: 10.2147/PGPM.S391394. View